The occurrence rates of germline MEN1 mutations in individuals presenting with a single apparent sporadic pancreatic NET at similarly younger age, has not been established, and the current guidelines recommend that MEN1 mutational analysis should be considered in those with gastrinoma or multiple pancreatic NETS (Thakker et al., 2012). This evidence concerns the gene MEN1 and pancreatic neuroendocrine tumor.